Skip to main content
. 2007 Aug 1;110(13):4543–4551. doi: 10.1182/blood-2007-05-092130

Figure 5.

Figure 5

Preservation of CCR7+ CD4+ T cells at day 30 is associated with improved survival after CBT. We examined actuarial survival in patients stratified by the median ratio of CCR7+ to CCR7CD4+ T cells at post-CBT day 30. Patients above the median ratio had significantly improved survival after CBT (median survival 240 days vs 700 days, P = .013).